
Hu Xiaofang
Yuanhe chenkun gives full play to the value discovery function of the master fund, explores, supports and accompanies excellent fund management team, and realizes industrial support and investment demand. Relying on in-depth understanding and judgment of the industry, Yuanhe chenkun focuses on the long-term development dividend of medical and health, as well as the industrial upgrading and innovation opportunities driven by intelligence and digitization.
By virtue of the master fund's portfolio allocation ability and its own scale effect, yuanhechengkun accurately grasps the demands of capital and resource sides, continues to play the pivotal role of industrial development and resource convergence, provides good opportunities for resource sides to participate in China's scientific and technological innovation development, and promotes the development of real economy with the rapid growth of emerging industries.
He is a doctor of biomedical engineering from Shanghai Jiaotong University and a postdoctoral student from Harvard University. He was a professor of med-x Research Institute of Shanghai Jiaotong University, the managing director of Tianshili capital Huajin Jintian fund and the managing director of Chende capital. Dr. Hu has more than 20 years of biomedical research and investment experience, with profound professional background and rich industry resources. Leading projects: Guangzhou kangliming, Zhejiang aikono, Shanghai Lvdi, Shanghai kailian, Suzhou Suqiao, Suzhou Chuanglan, Shanghai Ruijing, etc.
Related Teams

Inquiry: fof@oriza.com
Join Us: hr@oriza.com
Suzhou: +86-0512-66969722
Beijing: +86-010-65000132

Scan QR code
Copyright © Oriza FOFs All rights reserved 京ICP备16013165号-1 Powered by 300.cn